Asosiy kontentga oʻtish

Matt Shirley

1 ta ish

Springer Nature (New Zealand)

  1. Olaratumab: First Global Approval

    Matt Shirley

    Sharh maqolaSarcoma Diagnosis and TreatmentDrugs20160 iqtibos
    ABI